A citation-based method for searching scientific literature


List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
Alexander Muik, Ann-Kathrin Wallisch, Bianca Sänger, Kena A Swanson, Julia Mühl, Wei Chen, Hui Cai, Daniel Maurus, Ritu Sarkar, Özlem Türeci,[...]. Science 2021
361
100

The RosettaDock server for local protein-protein docking.
Sergey Lyskov, Jeffrey J Gray. Nucleic Acids Res 2008
368
100

SARS-CoV-2 variants, spike mutations and immune escape.
William T Harvey, Alessandro M Carabelli, Ben Jackson, Ravindra K Gupta, Emma C Thomson, Ewan M Harrison, Catherine Ludden, Richard Reeve, Andrew Rambaut, Sharon J Peacock,[...]. Nat Rev Microbiol 2021
100

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
Yan Wu, Feiran Wang, Chenguang Shen, Weiyu Peng, Delin Li, Cheng Zhao, Zhaohui Li, Shihua Li, Yuhai Bi, Yang Yang,[...]. Science 2020
677
100

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Bette Korber, Will M Fischer, Sandrasegaram Gnanakaran, Hyejin Yoon, James Theiler, Werner Abfalterer, Nick Hengartner, Elena E Giorgi, Tanmoy Bhattacharya, Brian Foley,[...]. Cell 2020
100


LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.
A C Wallace, R A Laskowski, J M Thornton. Protein Eng 1995
100

Impact of the Delta variant on vaccine efficacy and response strategies.
Lianlian Bian, Qiushuang Gao, Fan Gao, Qian Wang, Qian He, Xing Wu, Qunying Mao, Miao Xu, Zhenglun Liang. Expert Rev Vaccines 2021
88
100

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.
Renhong Yan, Yuanyuan Zhang, Yaning Li, Lu Xia, Yingying Guo, Qiang Zhou. Science 2020
100

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M E Duyvesteyn, Helen M Ginn, Loic Carrique, Tomas Malinauskas, Reinis R Ruza, Pranav N M Shah,[...]. Cell Host Microbe 2020
195
50

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.
Pengfei Wang, Ryan G Casner, Manoj S Nair, Maple Wang, Jian Yu, Gabriele Cerutti, Lihong Liu, Peter D Kwong, Yaoxing Huang, Lawrence Shapiro,[...]. Cell Host Microbe 2021
341
50

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
Kai Wu, Anne P Werner, Matthew Koch, Angela Choi, Elisabeth Narayanan, Guillaume B E Stewart-Jones, Tonya Colpitts, Hamilton Bennett, Seyhan Boyoglu-Barnum, Wei Shi,[...]. N Engl J Med 2021
271
50

UCSF Chimera--a visualization system for exploratory research and analysis.
Eric F Pettersen, Thomas D Goddard, Conrad C Huang, Gregory S Couch, Daniel M Greenblatt, Elaine C Meng, Thomas E Ferrin. J Comput Chem 2004
50

Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
William C Hwang, Yaqiong Lin, Eugenio Santelli, Jianhua Sui, Lukasz Jaroszewski, Boguslaw Stec, Michael Farzan, Wayne A Marasco, Robert C Liddington. J Biol Chem 2006
153
50


Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.
Jianhua Sui, Wenhui Li, Akikazu Murakami, Azaibi Tamin, Leslie J Matthews, Swee Kee Wong, Michael J Moore, Aimee St Clair Tallarico, Mobolaji Olurinde, Hyeryun Choe,[...]. Proc Natl Acad Sci U S A 2004
447
50

GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.
Berk Hess, Carsten Kutzner, David van der Spoel, Erik Lindahl. J Chem Theory Comput 2008
50

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech,[...]. Nature 2021
50

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Muhammad E H Chowdhury, Majid Sharifi, Setareh Haghighat, Mojtaba Falahati. Biomed Pharmacother 2020
39
50


Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees.
Alison Tarke, John Sidney, Nils Methot, Yun Zhang, Jennifer M Dan, Benjamin Goodwin, Paul Rubiro, Aaron Sutherland, Ricardo da Silva Antunes, April Frazier,[...]. bioRxiv 2021
82
50


SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, Prerna Arora, Anzhalika Sidarovich, Anna-Sophie Moldenhauer, Martin S Winkler,[...]. Cell Rep 2021
146
50

Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Bin Ju, Qi Zhang, Jiwan Ge, Ruoke Wang, Jing Sun, Xiangyang Ge, Jiazhen Yu, Sisi Shan, Bing Zhou, Shuo Song,[...]. Nature 2020
50

STAT3 signalling is required for leptin regulation of energy balance but not reproduction.
Sarah H Bates, Walter H Stearns, Trevor A Dundon, Markus Schubert, Annette W K Tso, Yongping Wang, Alexander S Banks, Hugh J Lavery, Asma K Haq, Eleftheria Maratos-Flier,[...]. Nature 2003
747
50


The PSIPRED protein structure prediction server.
L J McGuffin, K Bryson, D T Jones. Bioinformatics 2000
50

Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.
Baisheng Li, Aiping Deng, Kuibiao Li, Yao Hu, Zhencui Li, Yaling Shi, Qianling Xiong, Zhe Liu, Qianfang Guo, Lirong Zou,[...]. Nat Commun 2022
173
50

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Luca Piccoli, Young-Jun Park, M Alejandra Tortorici, Nadine Czudnochowski, Alexandra C Walls, Martina Beltramello, Chiara Silacci-Fregni, Dora Pinto, Laura E Rosen, John E Bowen,[...]. Cell 2020
665
50

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.
Meng Yuan, Nicholas C Wu, Xueyong Zhu, Chang-Chun D Lee, Ray T Y So, Huibin Lv, Chris K P Mok, Ian A Wilson. Science 2020
931
50

Current updates on computer aided protein modeling and designing.
Faez Iqbal Khan, Dong-Qing Wei, Ke-Ren Gu, Md Imtaiyaz Hassan, Shams Tabrez. Int J Biol Macromol 2016
74
50

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Rui Shi, Chao Shan, Xiaomin Duan, Zhihai Chen, Peipei Liu, Jinwen Song, Tao Song, Xiaoshan Bi, Chao Han, Lianao Wu,[...]. Nature 2020
822
50

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
Johanna Hansen, Alina Baum, Kristen E Pascal, Vincenzo Russo, Stephanie Giordano, Elzbieta Wloga, Benjamin O Fulton, Ying Yan, Katrina Koon, Krunal Patel,[...]. Science 2020
743
50


Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera,[...]. N Engl J Med 2021
50

PDBsum: Structural summaries of PDB entries.
Roman A Laskowski, Jagoda Jabłońska, Lukáš Pravda, Radka Svobodová Vařeková, Janet M Thornton. Protein Sci 2018
436
50

The biological and clinical significance of emerging SARS-CoV-2 variants.
Kaiming Tao, Philip L Tzou, Janin Nouhin, Ravindra K Gupta, Tulio de Oliveira, Sergei L Kosakovsky Pond, Daniela Fera, Robert W Shafer. Nat Rev Genet 2021
321
50

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Lizhou Zhang, Cody B Jackson, Huihui Mou, Amrita Ojha, Haiyong Peng, Brian D Quinlan, Erumbi S Rangarajan, Andi Pan, Abigail Vanderheiden, Mehul S Suthar,[...]. Nat Commun 2020
488
50

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
Nuno R Faria, Thomas A Mellan, Charles Whittaker, Ingra M Claro, Darlan da S Candido, Swapnil Mishra, Myuki A E Crispim, Flavia C S Sales, Iwona Hawryluk, John T McCrone,[...]. Science 2021
682
50

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.
Finlay Campbell, Brett Archer, Henry Laurenson-Schafer, Yuka Jinnai, Franck Konings, Neale Batra, Boris Pavlin, Katelijn Vandemaele, Maria D Van Kerkhove, Thibaut Jombart,[...]. Euro Surveill 2021
382
50

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie,[...]. Cell 2020
874
50

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Petra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Isabella A T M Ferreira, Rawlings Datir, Dami A Collier, Anna Albecka, Sujeet Singh,[...]. Nature 2021
543
50

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Pengfei Wang, Manoj S Nair, Lihong Liu, Sho Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, Peter D Kwong,[...]. Nature 2021
50

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
50

Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.
Andreina Baj, Federica Novazzi, Francesca Drago Ferrante, Angelo Genoni, Elena Tettamanzi, Giuseppe Catanoso, Daniela Dalla Gasperina, Francesco Dentali, Daniele Focosi, Fabrizio Maggi. Emerg Microbes Infect 2021
10
50

Molecular dynamics simulations and principal component analysis on human laforin mutation W32G and W32G/K87A.
P S Srikumar, K Rohini, Perumbilavil Kaithamanakallam Rajesh. Protein J 2014
24
50


Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
Yuan Huang, Chan Yang, Xin-Feng Xu, Wei Xu, Shu-Wen Liu. Acta Pharmacol Sin 2020
846
50

Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S Gerstman, Giri Narasimhan, Prem P Chapagain. Biochem Biophys Res Commun 2021
37
50

Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis.
Yihui Huang, Mengqi Tu, Shipei Wang, Sichao Chen, Wei Zhou, Danyang Chen, Lin Zhou, Min Wang, Yan Zhao, Wen Zeng,[...]. Travel Med Infect Dis 2020
125
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.